Tag: Remogliflozin + Vildagliptin
Glenmark launches drug in India to treat Type 2 diabetes
Glenmark Pharmaceuticals has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium Glucose Co-Transporter Inhibitor (SGLT2i) – Remogliflozin Etabonate and another...
Latest posts
Govt Job: For M.Pharm, M.Sc, Ph.D at National Innovation Foundation
The National Innovation Foundation – India, is India's national initiative to strengthen the grassroots technological innovations and outstanding traditional knowledge.
Authors
